Zhou, Qiang
He, Qiao
He, Wenwu
Wang, Chenghao
Liu, Guangyuan
Wang, Kangning
Li, Haojun
Li, Jialong
Xiao, Wenguang
Fang, Qiang
Peng, Lin
Han, Yongtao
Wang, Dongsheng
Leng, Xuefeng
Funding for this research was provided by:
Department of Science and Technology of Sichuan Province (2023YFQ0056, 2023NSFSC1887, 2023YFS0044, 2020YFH0169)
National Key Research and Development Program of China (2022YFC2403400)
Wu Jieping Medical Research Project (320.6750.2020-15-3)
Sichuan Province Clinical Key Specialty Construction Project and the Japan China Sasakawa Medical Fellowship (2021 No.85)
Article History
Received: 14 April 2023
Accepted: 25 October 2023
First Online: 30 November 2023
Declarations
:
: The present study was conducted in accordance with the Declaration of Helsinki.Approval of the research protocol by an Institutional Reviewer Board: The Sichuan Cancer Hospital & Institute Ethics Committee approved this study (No. SCCHEC-02-2022-050).Informed Consent: The need for written informed consent was waived by the Sichuan Cancer Hospital & Institute Ethics Committee due to the retrospective nature of the study.Registry and the Registration No. of the study: N/A.Animal Studies: N/A.
: Not applicable.
: The authors declare no competing interests.